Christchurch to rebuild its microbial collections

Thursday, 21 April, 2011

Microbial cultures used in the development of natural insecticides were damaged in the Christchurch earthquake but will soon be available again thanks to Australia’s National Measurement Institute (NMI).

NMI is working with Greentide Ltd to help rebuild important microbial culture collections damaged in the devastating earthquake.

Labs outside Christchurch where Greentide conducts some of its research and the important collection of fungi and other microbes indigenous to New Zealand were badly damaged. Some of the fungi are not known to be stored anywhere else in the world.

Abandoned when the quake struck, many of the cultures could not be recovered when researchers returned two weeks later.

Innovation Minister Senator Kim Carr said NMI was helping Greentide rebuild cultures of the microorganisms that it had lost.

“NMI is an international depository authority for the Budapest Treaty on the International Recognition of the Deposit of Micro-organisms for the Purposes of Patent Procedure. So it had samples of the New Zealand microorganisms in its collection in Port Melbourne.

“As one of a few depositories in the Asia-Pacific region, NMI receives and stores microorganisms for up to 30 years,” Senator Carr said.

“Luckily, Greentide had deposited samples of the cultures that were damaged in Christchurch with NMI. We hope that research into New Zealand’s indigenous fungi - and the pesticide - can continue with these ‘rebuilt’ collections.

“The company can be proud of its decision to lodge those samples. It’s a decision that will help New Zealand farmers produce healthier crops for consumers quickly and efficiently.”

Related News

A simple finger prick can be used to diagnose Alzheimer's

A new study is paving the way for a more accessible method of Alzheimer's testing, requiring...

Experimental blood test detects early-stage pancreatic cancer

The new test works by detecting two sugars — CA199.STRA and CA19-9 — that are...

Biomarkers for dementia vary with time of day

Biomarkers used to diagnose Alzheimer's, including a promising marker for early diagnosis of...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd